相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics
Emanuel Wyler et al.
MOLECULAR THERAPY (2022)
A comparison of Remdesivir versus gold cluster in COVID-19 animal model: A better therapeutic outcome of gold cluster
Zhesheng He et al.
NANO TODAY (2022)
Differential susceptibility of SARS-CoV-2 in animals: Evidence of ACE2 host receptor distribution in companion animals, livestock and wildlife by immunohistochemical characterisation
Fabian Z. X. Lean et al.
TRANSBOUNDARY AND EMERGING DISEASES (2022)
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Anant Parasher
POSTGRADUATE MEDICAL JOURNAL (2021)
Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
Wenyu Fu et al.
PROTEIN & CELL (2021)
Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters
Lisa Allnoch et al.
VIRUSES-BASEL (2021)
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
Federico Angriman et al.
LANCET RESPIRATORY MEDICINE (2021)
Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2
Kathrin Becker et al.
FRONTIERS IN IMMUNOLOGY (2021)
Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity
Voddu Suresh et al.
FASEB JOURNAL (2021)
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rita E. Chen et al.
NATURE (2021)
SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney
Magen Ellen Francis et al.
PLOS PATHOGENS (2021)
N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study
Stelios F. Assimakopoulos et al.
INFECTIOUS DISEASES (2021)
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione
Desiree Bartolini et al.
REDOX BIOLOGY (2021)
N-Acetylcysteine as Adjuvant Therapy for COVID-19-A Perspective on the Current State of the Evidence
Kon Ken Wong et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury
Roberto F. Nicosia et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection
Zi-Wei Ye et al.
EMERGING MICROBES & INFECTIONS (2021)
Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy
Mehmet Akif Somdas et al.
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY (2020)
On the use of corticosteroids for 2019-nCoV pneumonia
Lianhan Shang et al.
LANCET (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2
Francis L. Poe et al.
MEDICAL HYPOTHESES (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Rationale for the use ofN-acetylcysteine in both prevention and adjuvant therapy of COVID-19
Silvio De Flora et al.
FASEB JOURNAL (2020)
Is a Cytokine Storm Relevant to COVID-19?
Pratik Sinha et al.
JAMA INTERNAL MEDICINE (2020)
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J. F. Kaptein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 and Oxidative Stress
B. Chernyak et al.
BIOCHEMISTRY-MOSCOW (2020)
N-Acetylcysteine to Combat COVID-19: An Evidence Review
Zhongcheng Shi et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Medical and Dietary Uses of N-Acetylcysteine
Spela Salamon et al.
ANTIOXIDANTS (2019)
Oral N-acetylcysteine and exercise tolerance in mild chronic obstructive pulmonary disease
Daniel M. Hirai et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency
Edit Dosa et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
Intraperitoneal N-acetylcysteine for acute iron intoxication in rats
Rachelle Breitbart et al.
DRUG AND CHEMICAL TOXICOLOGY (2011)
N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection
A. Garozzo et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)
Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis
EB Kurutas et al.
MEDIATORS OF INFLAMMATION (2005)
Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology
DP Arfsten et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2004)